Merck & Co., Inc. (MRK)
USD 98.34
(-1.72%)
USD 98.34
(-1.72%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 43.98 Billion USD | 73.95% |
| 2022 | 23.59 Billion USD | 7.82% |
| 2021 | 21.87 Billion USD | -2.12% |
| 2020 | 22.35 Billion USD | 9.1% |
| 2019 | 20.48 Billion USD | 3.19% |
| 2018 | 19.85 Billion USD | 0.21% |
| 2017 | 19.81 Billion USD | 16.84% |
| 2016 | 16.95 Billion USD | -0.36% |
| 2015 | 17.01 Billion USD | -9.42% |
| 2014 | 18.78 Billion USD | -3.23% |
| 2013 | 19.41 Billion USD | -7.31% |
| 2012 | 20.94 Billion USD | -5.66% |
| 2011 | 22.2 Billion USD | -8.4% |
| 2010 | 24.23 Billion USD | 68.44% |
| 2009 | 14.38 Billion USD | 18.11% |
| 2008 | 12.18 Billion USD | -2.07% |
| 2007 | 12.43 Billion USD | -3.93% |
| 2006 | 12.94 Billion USD | 17.67% |
| 2005 | 11 Billion USD | -3.11% |
| 2004 | 11.35 Billion USD | 16.91% |
| 2003 | 9.71 Billion USD | 7.11% |
| 2002 | 9.06 Billion USD | 0.64% |
| 2001 | 9.01 Billion USD | -10.85% |
| 2000 | 10.1 Billion USD | 20.15% |
| 1999 | 8.41 Billion USD | 14.5% |
| 1998 | 7.34 Billion USD | 4.71% |
| 1997 | 7.01 Billion USD | 12.17% |
| 1996 | 6.25 Billion USD | 13.98% |
| 1995 | 5.48 Billion USD | 3.88% |
| 1994 | 5.28 Billion USD | 17.38% |
| 1993 | 4.5 Billion USD | 2.39% |
| 1992 | 4.39 Billion USD | 15.03% |
| 1991 | 3.82 Billion USD | 9.32% |
| 1990 | 3.49 Billion USD | 17.1% |
| 1989 | 2.98 Billion USD | 8.51% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 8.49 Billion USD | 51.86% |
| 2024 Q1 | 6.47 Billion USD | -47.91% |
| 2024 Q2 | 5.59 Billion USD | -13.61% |
| 2023 Q4 | 12.43 Billion USD | 113.37% |
| 2023 Q2 | 16.02 Billion USD | 137.2% |
| 2023 Q1 | 6.75 Billion USD | 4.53% |
| 2023 Q3 | 5.82 Billion USD | -63.64% |
| 2023 FY | 41.03 Billion USD | 73.95% |
| 2022 Q4 | 6.46 Billion USD | -6.61% |
| 2022 FY | 23.59 Billion USD | 7.82% |
| 2022 Q2 | 5.31 Billion USD | 8.39% |
| 2022 Q3 | 6.91 Billion USD | 30.3% |
| 2022 Q1 | 4.89 Billion USD | -16.94% |
| 2021 FY | 21.87 Billion USD | -2.12% |
| 2021 Q1 | 4.59 Billion USD | -48.45% |
| 2021 Q2 | 6.6 Billion USD | 43.55% |
| 2021 Q3 | 4.78 Billion USD | -27.58% |
| 2021 Q4 | 5.89 Billion USD | 23.36% |
| 2020 Q2 | 4.17 Billion USD | -12.47% |
| 2020 FY | 22.35 Billion USD | 9.1% |
| 2020 Q1 | 4.76 Billion USD | -12.38% |
| 2020 Q3 | 5.4 Billion USD | 29.71% |
| 2020 Q4 | 8.92 Billion USD | 64.95% |
| 2019 Q1 | 4.35 Billion USD | -10.32% |
| 2019 Q2 | 4.9 Billion USD | 12.51% |
| 2019 Q3 | 5.79 Billion USD | 18.2% |
| 2019 FY | 20.48 Billion USD | 3.19% |
| 2019 Q4 | 5.43 Billion USD | -6.15% |
| 2018 Q2 | 4.78 Billion USD | -16.16% |
| 2018 FY | 19.85 Billion USD | 0.21% |
| 2018 Q1 | 5.7 Billion USD | 17.37% |
| 2018 Q3 | 4.51 Billion USD | -5.67% |
| 2018 Q4 | 4.85 Billion USD | 7.67% |
| 2017 Q4 | 4.86 Billion USD | -29.28% |
| 2017 FY | 19.81 Billion USD | 16.84% |
| 2017 Q1 | 4.3 Billion USD | -40.6% |
| 2017 Q2 | 4.28 Billion USD | -0.46% |
| 2017 Q3 | 6.87 Billion USD | 60.49% |
| 2016 Q3 | 4.05 Billion USD | -11.98% |
| 2016 FY | 16.95 Billion USD | -0.36% |
| 2016 Q2 | 4.6 Billion USD | 15.89% |
| 2016 Q4 | 7.24 Billion USD | 78.51% |
| 2016 Q1 | 3.97 Billion USD | -9.88% |
| 2015 Q4 | 4.41 Billion USD | 11.1% |
| 2015 Q2 | 4.29 Billion USD | -1.01% |
| 2015 Q1 | 4.33 Billion USD | -16.71% |
| 2015 FY | 17.01 Billion USD | -9.42% |
| 2015 Q3 | 3.97 Billion USD | -7.5% |
| 2014 FY | 18.78 Billion USD | -3.23% |
| 2014 Q3 | 4.63 Billion USD | -0.06% |
| 2014 Q2 | 4.63 Billion USD | 7.64% |
| 2014 Q1 | 4.3 Billion USD | -10.57% |
| 2014 Q4 | 5.2 Billion USD | 12.39% |
| 2013 FY | 19.41 Billion USD | -7.31% |
| 2013 Q1 | 4.89 Billion USD | -12.83% |
| 2013 Q4 | 4.81 Billion USD | 7.93% |
| 2013 Q3 | 4.46 Billion USD | -14.84% |
| 2013 Q2 | 5.24 Billion USD | 7.09% |
| 2012 Q3 | 4.98 Billion USD | -8.0% |
| 2012 Q4 | 5.61 Billion USD | 12.71% |
| 2012 FY | 20.94 Billion USD | -5.66% |
| 2012 Q1 | 4.93 Billion USD | -19.39% |
| 2012 Q2 | 5.41 Billion USD | 9.68% |
| 2011 Q1 | 5.32 Billion USD | -34.26% |
| 2011 Q4 | 6.12 Billion USD | 15.66% |
| 2011 Q2 | 5.4 Billion USD | 1.58% |
| 2011 Q3 | 5.29 Billion USD | -2.07% |
| 2011 FY | 22.2 Billion USD | -8.4% |
| 2010 Q2 | 5.35 Billion USD | 1.54% |
| 2010 Q3 | 5.51 Billion USD | 2.99% |
| 2010 Q4 | 8.09 Billion USD | 46.81% |
| 2010 FY | 24.23 Billion USD | 68.44% |
| 2010 Q1 | 5.27 Billion USD | -2.83% |
| 2009 Q3 | 2.97 Billion USD | -4.65% |
| 2009 Q4 | 5.42 Billion USD | 82.13% |
| 2009 Q2 | 3.12 Billion USD | 9.37% |
| 2009 Q1 | 2.85 Billion USD | -12.05% |
| 2009 FY | 14.38 Billion USD | 18.11% |
| 2008 Q4 | 3.24 Billion USD | 11.97% |
| 2008 FY | 12.18 Billion USD | -2.07% |
| 2008 Q3 | 2.9 Billion USD | -6.39% |
| 2008 Q1 | 2.93 Billion USD | -5.44% |
| 2008 Q2 | 3.09 Billion USD | 5.69% |
| 2007 Q3 | 3.39 Billion USD | 8.92% |
| 2007 FY | 12.43 Billion USD | -3.93% |
| 2007 Q1 | 2.83 Billion USD | -30.4% |
| 2007 Q2 | 3.11 Billion USD | 9.96% |
| 2007 Q4 | 3.1 Billion USD | -8.57% |
| 2006 Q4 | 4.06 Billion USD | 22.7% |
| 2006 FY | 12.94 Billion USD | 17.67% |
| 2006 Q3 | 3.31 Billion USD | 14.09% |
| 2006 Q2 | 2.9 Billion USD | 9.39% |
| 2006 Q1 | 2.65 Billion USD | -15.86% |
| 2005 Q3 | 2.68 Billion USD | -0.68% |
| 2005 Q2 | 2.7 Billion USD | 10.2% |
| 2005 Q1 | 2.45 Billion USD | -29.42% |
| 2005 FY | 11 Billion USD | -3.11% |
| 2005 Q4 | 3.15 Billion USD | 17.66% |
| 2004 Q4 | 3.47 Billion USD | 30.02% |
| 2004 Q3 | 2.67 Billion USD | 2.69% |
| 2004 Q2 | 2.6 Billion USD | -0.21% |
| 2004 Q1 | 2.6 Billion USD | -4.32% |
| 2004 FY | 11.35 Billion USD | 16.91% |
| 2003 Q4 | 2.72 Billion USD | 21.67% |
| 2003 FY | 9.71 Billion USD | 7.11% |
| 2003 Q2 | 2.41 Billion USD | 2.43% |
| 2003 Q3 | 2.24 Billion USD | -7.17% |
| 2003 Q1 | 2.35 Billion USD | -8.39% |
| 2002 Q3 | 2.11 Billion USD | -2.11% |
| 2002 FY | 9.06 Billion USD | 0.64% |
| 2002 Q4 | 2.57 Billion USD | 21.63% |
| 2002 Q2 | 2.16 Billion USD | 5.55% |
| 2002 Q1 | 2.04 Billion USD | -13.18% |
| 2001 Q3 | 2.19 Billion USD | -5.21% |
| 2001 Q4 | 2.35 Billion USD | 7.18% |
| 2001 FY | 9.01 Billion USD | -10.85% |
| 2001 Q1 | 2.13 Billion USD | -30.51% |
| 2001 Q2 | 2.32 Billion USD | 8.72% |
| 2000 Q3 | 2.44 Billion USD | 4.93% |
| 2000 Q2 | 2.33 Billion USD | 3.09% |
| 2000 Q1 | 2.26 Billion USD | -9.52% |
| 2000 Q4 | 3.07 Billion USD | 25.59% |
| 2000 FY | 10.1 Billion USD | 20.15% |
| 1999 Q3 | 2.07 Billion USD | 5.85% |
| 1999 Q2 | 1.95 Billion USD | 4.17% |
| 1999 FY | 8.41 Billion USD | 14.5% |
| 1999 Q4 | 2.49 Billion USD | 20.48% |
| 1999 Q1 | 1.88 Billion USD | -13.06% |
| 1998 Q4 | 2.16 Billion USD | 33.39% |
| 1998 Q2 | 1.54 Billion USD | 8.12% |
| 1998 FY | 7.34 Billion USD | 4.71% |
| 1998 Q3 | 1.62 Billion USD | 4.77% |
| 1998 Q1 | 1.43 Billion USD | -43.39% |
| 1997 Q2 | 1.48 Billion USD | 0.8% |
| 1997 FY | 7.01 Billion USD | 12.17% |
| 1997 Q3 | 1.52 Billion USD | 2.2% |
| 1997 Q4 | 2.52 Billion USD | 66.25% |
| 1997 Q1 | 1.47 Billion USD | -37.02% |
| 1996 FY | 6.25 Billion USD | 13.98% |
| 1996 Q2 | 1.34 Billion USD | 10.76% |
| 1996 Q3 | 1.35 Billion USD | 1.3% |
| 1996 Q4 | 2.34 Billion USD | 72.62% |
| 1996 Q1 | 1.21 Billion USD | -39.71% |
| 1995 Q1 | 1.1 Billion USD | -44.22% |
| 1995 Q3 | 1.14 Billion USD | -6.47% |
| 1995 FY | 5.48 Billion USD | 3.88% |
| 1995 Q4 | 2 Billion USD | 75.05% |
| 1995 Q2 | 1.22 Billion USD | 10.91% |
| 1994 Q4 | 1.98 Billion USD | 68.92% |
| 1994 FY | 5.28 Billion USD | 17.38% |
| 1994 Q1 | 1.06 Billion USD | 38.02% |
| 1994 Q2 | 1.06 Billion USD | -0.38% |
| 1994 Q3 | 1.17 Billion USD | 10.58% |
| 1993 Q1 | 952.6 Million USD | -36.52% |
| 1993 Q2 | 1.77 Billion USD | 86.62% |
| 1993 FY | 4.5 Billion USD | 2.39% |
| 1993 Q4 | 772 Million USD | -22.73% |
| 1993 Q3 | 999.1 Million USD | -43.8% |
| 1992 Q1 | 924.7 Million USD | -27.63% |
| 1992 Q2 | 915.2 Million USD | -1.03% |
| 1992 FY | 4.39 Billion USD | 15.03% |
| 1992 Q3 | 1.05 Billion USD | 15.36% |
| 1992 Q4 | 1.5 Billion USD | 42.13% |
| 1991 Q4 | 1.27 Billion USD | 51.96% |
| 1991 FY | 3.82 Billion USD | 9.32% |
| 1991 Q3 | 840.8 Million USD | -6.78% |
| 1991 Q2 | 902 Million USD | -3.35% |
| 1991 Q1 | 933.3 Million USD | -21.57% |
| 1990 FY | 3.49 Billion USD | 17.1% |
| 1990 Q4 | 1.19 Billion USD | 49.27% |
| 1990 Q3 | 797.2 Million USD | 4.63% |
| 1990 Q2 | 761.9 Million USD | 2.02% |
| 1990 Q1 | 746.8 Million USD | -27.04% |
| 1989 Q1 | - USD | 100.0% |
| 1989 Q4 | 1.02 Billion USD | 55.7% |
| 1989 Q3 | 657.4 Million USD | 0.0% |
| 1989 FY | 2.98 Billion USD | 8.51% |
| 1989 Q2 | - USD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AbbVie Inc. | 24.83 Billion USD | -77.125% |
| Bristol-Myers Squibb Company | 34.31 Billion USD | -28.199% |
| Bristol-Myers Squibb Company Ce | 34.31 Billion USD | -28.199% |
| Johnson & Johnson | 58.6 Billion USD | 24.941% |
| Eli Lilly and Company | 16.71 Billion USD | -163.147% |
| Novartis AG | 24.87 Billion USD | -76.869% |
| Organon & Co. | 2.41 Billion USD | -1718.479% |
| Pfizer Inc. | 25.45 Billion USD | -72.845% |